Cargando…
GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models
Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by lymphocytic infiltrates in the salivary and lachrymal glands resulting in oral and ocular dryness. There are no clinically approved therapies to slow the progression of SS. Immune cells possess receptors for the neurotransmitte...
Autores principales: | Song, Min, Tian, Jide, Middleton, Blake, Nguyen, Cuong Q., Kaufman, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773584/ https://www.ncbi.nlm.nih.gov/pubmed/35052808 http://dx.doi.org/10.3390/biomedicines10010129 |
Ejemplares similares
-
GABA administration prevents severe illness and death following coronavirus infection in mice
por: Tian, Jide, et al.
Publicado: (2020) -
GABA(A)-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice
por: Tian, Jide, et al.
Publicado: (2021) -
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017) -
Current Concepts: Mouse Models of Sjögren's Syndrome
por: Lavoie, Tegan N., et al.
Publicado: (2011) -
The GABA and GABA-Receptor System in Inflammation, Anti-Tumor Immune Responses, and COVID-19
por: Tian, Jide, et al.
Publicado: (2023)